Cipla to sell 51.18% stake in Cipla Quality Chemical Industries

15 Mar 2023 Evaluate

Cipla and its wholly owned subsidiaries -- Cipla (EU), UK and Meditab Holdings, Mauritius, have entered into a Share Purchase agreement with Africa Capitalworks SSA 3 on March 14, 2023 for sale of 51.18% stake held in Cipla Quality Chemical Industries (CQCIL), Uganda. Subsequent to the sale, CQCIL will cease to be a subsidiary of the Company. The proposed sale is expected to be completed by May 31, 2023.

The consideration to be received by Cipla (EU) and Meditab Holdings shall be in the range of $25-30 million which shall be subject to annualized audited EBITDA of CQCIL for FY23 and other adjustments as agreed between the parties and stated in the Share Purchase Agreement.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1498.65 -6.40 (-0.43%)
29-Dec-2025 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1723.60
Dr. Reddys Lab 1266.20
Cipla 1498.65
Zydus Lifesciences 903.65
Lupin 2095.90
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×